Cargando…

Clinical Value of Combined Detection of Serum sTim-3 and Pepsinogen for Gastric Cancer Diagnosis

PURPOSE: The present study aimed to evaluate the clinical value of the combined detection of soluble T cell immunoglobulinand mucin domain molecule 3 (sTim-3) and pepsinogen (PG) in sera for gastric cancer (GC) diagnosis. PATIENTS AND METHODS: The double antibody sandwich method was used to establis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Lingli, Hong, Jianfeng, Hu, Renjing, Yu, Xiaomei, Chen, Xindong, Zheng, Shaoxiong, Qin, Yuan, Zhou, Xiumei, Wang, Yigang, Zheng, Liping, Fang, Hongming, Liu, Pengfei, Huang, Biao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517425/ https://www.ncbi.nlm.nih.gov/pubmed/34675671 http://dx.doi.org/10.2147/CMAR.S328312

Ejemplares similares

Clinical Value of Combined Detection of Serum sTim-3 and CEA or CA19-9 for Postoperative Recurrence of Colorectal Cancer Diagnosis
por: Hong, Jianfeng, et al.
Publicado: (2023)

Increase in Serum Soluble Tim-3 Level Is Related to the Progression of Diseases After Hepatitis Virus Infection
por: Chen, Lingli, et al.
Publicado: (2022)

Clinical value of serum pepsinogen in the diagnosis and treatment of gastric diseases
por: Qin, Yuan, et al.
Publicado: (2023)

Establishment of a time‐resolved immunoassay for acute kidney injury based on the detection of Kim‐1
por: Shaoxiong, Zheng, et al.
Publicado: (2022)

Diagnostic value of serum pepsinogen I, pepsinogen II, and gastrin-17 levels for population-based screening for early-stage gastric cancer
por: Wang, Yaping, et al.
Publicado: (2020)

Gastric neoplasms and pepsinogen phenotypes.
por: Ellis, A., et al.
Publicado: (1982)

The Diagnostic Value of Serum Gastrin-17 and Pepsinogen for Gastric Cancer Screening in Eastern China
por: Shen, Hongzhang, et al.
Publicado: (2021)

sTim-3 alleviates liver injury via regulation of the immunity microenvironment and autophagy
por: Yang, Ying, et al.
Publicado: (2020)

The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer
por: Juan Cai, Wei, et al.
Publicado: (2017)

Polymorphisms in Pepsinogen C and miRNA Genes Associate with High Serum Pepsinogen II in Gastric Cancer Patients
por: Re, Valli De, et al.
Publicado: (2021)

Long-term Effect of Smoking on Serum Pepsinogen Values
por: Kikuchi, Shogo, et al.
Publicado: (2007)

Soluble Tim3 detection by time‐resolved fluorescence immunoassay and its application in membranous nephropathy
por: Chen, Ming, et al.
Publicado: (2020)

Elevated plasma sTIM-3 levels in patients with severe COVID-19
por: Ueland, Thor, et al.
Publicado: (2021)

The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China
por: Zhang, Xiao-mei, et al.
Publicado: (2014)

Is serum pepsinogen testing necessary in populationbased screening for gastric cancer?
por: Kim, Yeon-Ji, et al.
Publicado: (2020)

Clinical correlation between serum pepsinogen level and gastric atrophy in gastric neoplasm
por: Cha, Jae Hwang, et al.
Publicado: (2020)

Pepsinogen and Pepsin
por: Herriott, Roger M.
Publicado: (1962)

Association of serum pepsinogen with degree of gastric mucosal atrophy in an asymptomatic population
por: Cai, Hao-Lei, et al.
Publicado: (2021)

The relationship between pepsinogen C and gastric carcinogenesis: a transgene and population study
por: E., Ying, et al.
Publicado: (2023)

Pepsinogen I and II expressions in situ and their correlations with serum pesignogen levels in gastric cancer and its precancerous disease
por: Li, Ping, et al.
Publicado: (2013)

The Value of Pepsinogen in GC Screening: A Systematic Review and Meta-Analysis
por: Liu, Ling, et al.
Publicado: (2019)

Sensitivity and Specificity of Mass Screening for Gastric Cancer Using the Measurement of Serum Pepsinogens
por: Hattori, Yasushi, et al.
Publicado: (1995)

Significance of pepsinogen in screening for gastric intestinal metaplasia in Guangdong, China
por: Liu, Xujuan, et al.
Publicado: (2021)

Optimal Criteria and Diagnostic Ability of Serum Pepsinogen Values for Helicobacter pylori Infection
por: Kikuchi, Shogo, et al.
Publicado: (2019)

Correlation between negative expression of pepsinogen C and a series of phenotypic markers of gastric cancer in different gastric diseases
por: Jiang, Jingyi, et al.
Publicado: (2018)

Diagnostic Value of Serum Pepsinogen Levels for Screening Gastric Cancer and Atrophic Gastritis in Asymptomatic Individuals: A Cross-Sectional Study
por: Tong, Yuling, et al.
Publicado: (2021)

The panoramic picture of pepsinogen gene family with pan‐cancer
por: Shen, Shixuan, et al.
Publicado: (2020)

Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations
por: Miftahussurur, Muhammad, et al.
Publicado: (2020)

Serum gastrin 17, pepsinogen I and pepsinogen II in atrophic gastritis patients living in North-East of Iran
por: Hosseini, Mosalreza, et al.
Publicado: (2013)

Helicobacter pylori antibody and pepsinogen testing for predicting gastric microbiome abundance
por: Choi, Saemi, et al.
Publicado: (2019)

Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics
por: Broutet, N, et al.
Publicado: (2003)

Gastric Cancer Screening by Combined Determination of Serum Helicobacter pylori Antibody and Pepsinogen Concentrations: ABC Method for Gastric Cancer Screening
por: Chen, Xian-Zhe, et al.
Publicado: (2018)

Studies on the dynamics of pepsinogen distribution.
por: Spencer, R. P., et al.
Publicado: (1966)

IMMUNOLOGICAL STUDIES ON PEPSIN AND PEPSINOGEN
por: Seastone, C. V., et al.
Publicado: (1937)

ENZYMIC DEPHOSPHORYLATION OF PEPSIN AND PEPSINOGEN
por: Perlmann, Gertrude E.
Publicado: (1958)

MEMBRANES OF THE HUMAN PEPSINOGEN GRANULE
por: Lillibridge, Clinton B.
Publicado: (1961)

Accuracy and Cut-Off Values of Pepsinogens I, II and Gastrin 17 for Diagnosis of Gastric Fundic Atrophy: Influence of Gastritis
por: Nasrollahzadeh, Dariush, et al.
Publicado: (2011)

Clinical Application of Serum Pepsinogen I and II Levels for Mass Screening to Detect Gastric Cancer
por: Miki, Kazumasa, et al.
Publicado: (1993)

Mitochondrial DNA Copy Number Variations and Serum Pepsinogen Levels for Risk Assessment in Gastric Cancer
por: Alikhani, Mehdi, et al.
Publicado: (2021)

Serum pepsinogen level as a biomarker for atrophy, reflux esophagitis, and gastric cancer screening in Indonesia
por: Miftahussurur, Muhammad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tsokt8vbl9r8s6rm8lnd06gdm3